News
AstraZeneca granted licence for Nanoform’s AI technology
AstraZeneca (AZ) has been granted a global online licence by Nanoform to access its STARMAP artificial intelligence (AI) technology to screen molecules.
You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.
AstraZeneca (AZ) has been granted a global online licence by Nanoform to access its STARMAP artificial intelligence (AI) technology to screen molecules.